Mammoth Burn (capsule) V2
Natural health product licensed in Canada
- Licence holder
- iNutrition Inc.
- NPN or DIN-HM
- 80069219
- Status
- Active licence
- Licence date
- 6 May 2016
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Myristica fragrans Houtt.: L'huile essentielle de cette plante est interdite.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Citrus aurantium L.: La quantité ingérée de p-synéphrine doit être inférieure à 20 mg par dose journalière recommandée. L'étiquetage doit comporter un avertissement déconseillant l'emploi aux enfants, aux femmes enceintes ou allaitantes et en cas de traitement anti-hypertenseur. La caféine et les sources de caféine ne sont pas autorisées dans les compléments alimentaires contenant Citrus aurantium L.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Acide (S)-alpha-amino-4-hydroxybenzènepropanoïque Source : L-Tyrosine | 250 milligramme | Not calculated |
| Myristica fragrans Source : Graine(s) | 8 milligramme | Not calculated |
| 3,7-dihydro-1,3,7-triméthyl-1H-purine-2,6-dione Source : Caféine | 78 milligramme | Not calculated |
| Hydroxyde de (R)-3-carboxy-2-hydroxy-N,N,N-triméthyl-1-propanaminium, Sel interne Source : L-tartrate de carnitine | 170 milligramme | Not calculated |
| Citrus aurantium Source : Pelure (fruit) Potency : 30 % Synephrine | 30 milligramme | Not calculated |
| Citrus aurantium Source : Pelure (fruit) Potency : 1.4 % Octopamine | Not specified | Not calculated |
| Extrait de fèves de café vert Source : Coffea canephora - Graine Extraction ratio : 1.1:1 Dry plant equivalent : 110 milligramme Potency : 1 % Caffeine | 100 milligramme | Not calculated |
| Extrait de fèves de café vert Source : Coffea canephora - Graine Potency : 45 % Chlorogenic acids | Not specified | Not calculated |
| Olea europaea Source : Feuille Extraction ratio : 10:1 Dry plant equivalent : 500 milligramme Potency : 20 % Oleuropein | 50 milligramme | Not calculated |
Non-medicinal ingredients
silice, Hydroxypropylméthylcellulose, farine de riz, Dioxyde de titane, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2 Capsule | 2 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Source of Tyrosine, an amino acid involved in muscle protein synthesis. Helps temporarily to relieve fatigue, to promote endurance, and to enhance motor performance. Antioxidant. To be used with a program of reduced intake of dietary calories and increased physical activity (if possible) to help in weight management.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80069219
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Olea europaea
Read the warning, when it applies and the studies cited
OLIVE LEAF - OLEA EUROPAEA
Route of administration: Oral
Cautions and warnings
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you pregnant or breastfeeding (EMA 2017).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a kidney disorder (EMA 2017).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking other diuretics (EMA 2017).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Known adverse reactions
Condition of application: All products except those making a diuretic claim.
When using this product diuretic effect may occur.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.